title: Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery.
abstract: •Dermatomyositis in ovarian cancer responds to treatment with neo-adjuvant carboplatin and paclitaxel in conjunction with corticosteroids.•Recurrence of dermatomyositis symptoms is often the first sign of relapsed disease.•Prognosis of ovarian cancer in context of dermatomyositis is poor.
authors.affiliation: Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.
authors.forename: Alan
authors.initials: A
authors.lastname: Christie
authors.affiliation: Rheumatic Diseases Unit, Western General Hospital, Edinburgh, UK.
authors.forename: Neil
authors.initials: N
authors.lastname: McKay
authors.affiliation: Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.
authors.forename: Fiona
authors.initials: F
authors.lastname: Nussey
keywords: Dermatomyositis; Neo-adjuvant chemotherapy; Ovarian cancer